Overall I agree with your point but I want to make a squabble with your example. Purdue's marketing of Oxycontin definitely crossed my line of honesty, BUT the

Overall I agree with your point but I want to make a squabble with your example. Purdue's marketing of Oxycontin definitely crossed my line of honesty, BUT there has been, historically, an enormous amount of untreated pain in the US (probably everywhere), because of the stigma around those drugs. It's ok for someone to develop a tolerance and addiction to the drug if they have the actual pain issue. That is usually less disruptive to someone's life than living with crippling pain. In a way, getting opiate pain medication into the hands of more people is a good thing. The problem was a little more complicated- 1) Perdue promoted Oxycontin in a misleading way. 2) This happened during an economic downturn with our post-manufacturing economy turning out tons of people on disability, and others without a clear future. 3) Legislators freaked out, making it harder for doctors to prescribe opiates without making it easier for them to prescribe opiate treatment pills like suboxone, which basically forces addicted users of pharmaceuticals onto the street to score heroin. So it's a social, legislative, and corporate morality problem all at the same time.